MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹205 Cr | ₹84 Cr | ₹57 Cr | ₹24 Cr | ₹24 Cr |
What is the latest Total Non-Current Liabilities ratio of MARKSANS PHARMA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹205 Cr |
Mar2023 | ₹84 Cr |
Mar2022 | ₹57 Cr |
Mar2021 | ₹24 Cr |
Mar2020 | ₹24 Cr |
How is Total Non-Current Liabilities of MARKSANS PHARMA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹205 Cr | 143.34 | |
Mar2023 | ₹84 Cr | 47.80 | |
Mar2022 | ₹57 Cr | 140.72 | |
Mar2021 | ₹24 Cr | -1.88 | |
Mar2020 | ₹24 Cr | - |
Compare Total Non-Current Liabilities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹10,840.5 Cr | 1.2% | -16.2% | 61.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹417,472.0 Cr | 0.2% | -5.8% | 23.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,342.0 Cr | 4.8% | 0% | 53.8% | Stock Analytics | |
CIPLA | ₹114,754.0 Cr | -0.2% | -4.7% | 3.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,465.0 Cr | 1.9% | -10.9% | 0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,875.2 Cr | 3.2% | 0.1% | 28.1% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 1.2% |
-16.2% |
61.6% |
SENSEX | 1.7% |
-2.6% |
7.6% |
You may also like the below Video Courses